ADC Therapeutics SA Number Of Share Options Forfeited In Share-based Payment Arrangement
ADC Therapeutics SA (ADCT) reported Number Of Share Options Forfeited In Share-based Payment Arrangement of 2.11 million shares for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement · last filed 2023-11-07
- ADC Therapeutics SA number of share options forfeited in share-based payment arrangement for the quarter ending 2023-09-30 was 806.75K shares, a 246.01% increase year-over-year.
- ADC Therapeutics SA number of share options forfeited in share-based payment arrangement for the quarter ending 2023-06-30 was 836.40K shares, a 166.27% increase year-over-year.
- ADC Therapeutics SA number of share options forfeited in share-based payment arrangement for the quarter ending 2023-03-31 was 467.58K shares, a 71.43% increase year-over-year.
- ADC Therapeutics SA number of share options forfeited in share-based payment arrangement for the quarter ending 2022-12-31 was 538.14K shares, a 2581.16% increase year-over-year.
| Period end | Number Of Share Options Forfeited In Share-based Payment Arrangement 3 month | Number Of Share Options Forfeited In Share-based Payment Arrangement 6 month | Number Of Share Options Forfeited In Share-based Payment Arrangement 9 month | Number Of Share Options Forfeited In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-09-30 | 806.75K shares derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 1.64M shares derived: sum of 2 quarters · filed 2023-11-07 | 2.11M shares 6-K · filed 2023-11-07 | 2.65M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 836.40K shares derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | 1.30M shares 6-K · filed 2023-08-08 | 1.84M shares derived: sum of 3 quarters · filed 2023-08-08 | 2.08M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 467.58K shares 6-K · filed 2023-05-09 | 1.01M shares derived: sum of 2 quarters · filed 2023-05-09 | 1.24M shares derived: sum of 3 quarters · filed 2023-05-09 | 1.55M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 538.14K shares derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | 771.29K shares derived: sum of 2 quarters · filed 2023-03-15 | 1.09M shares derived: sum of 3 quarters · filed 2023-03-15 | 1.36M shares 20-F · filed 2023-03-15 |
| 2022-09-30 | 233.16K shares derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | 547.28K shares derived: sum of 2 quarters · filed 2022-11-08 | 820.03K shares 6-K · filed 2022-11-08 | 840.10K shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-06-30 | 314.12K shares derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | 586.88K shares 6-K · filed 2022-08-09 | 606.95K shares derived: sum of 3 quarters · filed 2023-03-15 | 687.67K shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-03-31 | 272.75K shares 6-K · filed 2022-05-09 | 292.82K shares derived: sum of 2 quarters · filed 2023-03-15 | 373.54K shares derived: sum of 3 quarters · filed 2023-03-15 | 394.39K shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-12-31 | 20.07K shares derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | 100.79K shares derived: sum of 2 quarters · filed 2023-03-15 | 121.63K shares derived: sum of 3 quarters · filed 2023-03-15 | 165.72K shares 20-F · filed 2023-03-15 |
| 2021-09-30 | 80.72K shares derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | 101.56K shares derived: sum of 2 quarters · filed 2021-11-02 | 145.65K shares 6-K · filed 2021-11-02 | |
| 2021-06-30 | 20.84K shares derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | 64.93K shares 6-K · filed 2021-08-03 | ||
| 2021-03-31 | 44.09K shares 6-K · filed 2021-05-06 | |||
| 2020-12-31 | 88.33K shares 20-F · filed 2023-03-15 | |||
| 2019-12-31 | 0.00 shares 20-F · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |